Clinical trial
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes
NCT03085771 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes
- Lead sponsor
- Karolinska University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 1, 2017
- Completion date
- December 12, 2024
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.